| Literature DB >> 32992344 |
Andreas Agathangelidis1, Anastasia Chatzidimitriou1,2, Katerina Gemenetzi1,3, Veronique Giudicelli4, Maria Karypidou1, Karla Plevova5,6, Zadie Davis7, Xiao-Jie Yan8, Sabine Jeromin9, Christof Schneider10, Lone Bredo Pedersen11, Renee C Tschumper12, Lesley-Ann Sutton2, Panagiotis Baliakas13, Lydia Scarfò14, Ellen J van Gastel15, Marine Armand16, Eugen Tausch17, Bella Biderman18, Constance Baer9, Davide Bagnara19, Alba Navarro20,21, Anne Langlois de Septenville16, Valentina Guido22, Gerlinde Mitterbauer-Hohendanner23, Aleksandar Dimovski24, Christian Brieghel11, Sarah Lawless25, Manja Meggendorfer9, Kamila Brazdilova5,6, Matthias Ritgen26, Monica Facco27,28, Cristina Tresoldi29, Andrea Visentin27,28, Andrea Patriarca30, Mark Catherwood25, Lisa Bonello31, Andrey Sudarikov18, Katrina Vanura23, Maria Roumelioti32, Hana Skuhrova Francova5, Theodoros Moysiadis1, Silvio Veronese22, Krzysztof Giannopoulos33, Larry Mansouri2, Teodora Karan-Djurasevic34, Raphael Sandaltzopoulos3, Csaba Bödör35, Franco Fais19,36, Arnon P Kater37, Irina Panovska38, Davide Rossi39, Salem Alshemmari40, Panagiotis Panagiotidis32, Paul Costeas41,42, Blanca Espinet43, Darko Antic44, Letizia Foroni45, Marco Montillo22, Livio Trentin27,28, Niki Stavroyianni46, Gianluca Gaidano30, Paola Francia di Celle31, Carsten Niemann11, Elias Campo20,21,47, Achilles Anagnostopoulos45, Christiane Pott26, Kirsten Fischer48, Michael Hallek49, David Oscier7, Stephan Stilgenbauer17, Claudia Haferlach9, Diane Jelinek50, Nicholas Chiorazzi8, Sarka Pospisilova5,6, Marie-Paule Lefranc4, Sofia Kossida4, Anton W Langerak15, Chrysoula Belessi51, Frederic Davi15, Richard Rosenquist2,52, Paolo Ghia14, Kostas Stamatopoulos1,2.
Abstract
Chronic lymphocytic leukemia (CLL) is characterized by the existence of subsets of patients with (quasi)identical, stereotyped B-cell receptor (BcR) immunoglobulins. Patients in certain major stereotyped subsets often display remarkably consistent clinicobiological profiles, suggesting that the study of BcR immunoglobulin stereotypy in CLL has important implications for understanding disease pathophysiology and refining clinical decision-making. Nevertheless, several issues remain open, especially pertaining to the actual frequency of BcR immunoglobulin stereotypy and major subsets, as well as the existence of higher-order connections between individual subsets. To address these issues, we investigated clonotypic IGHV-IGHD-IGHJ gene rearrangements in a series of 29 856 patients with CLL, by far the largest series worldwide. We report that the stereotyped fraction of CLL peaks at 41% of the entire cohort and that all 19 previously identified major subsets retained their relative size and ranking, while 10 new ones emerged; overall, major stereotyped subsets had a cumulative frequency of 13.5%. Higher-level relationships were evident between subsets, particularly for major stereotyped subsets with unmutated IGHV genes (U-CLL), for which close relations with other subsets, termed "satellites," were identified. Satellite subsets accounted for 3% of the entire cohort. These results confirm our previous notion that major subsets can be robustly identified and are consistent in relative size, hence representing distinct disease variants amenable to compartmentalized research with the potential of overcoming the pronounced heterogeneity of CLL. Furthermore, the existence of satellite subsets reveals a novel aspect of repertoire restriction with implications for refined molecular classification of CLL.Entities:
Mesh:
Substances:
Year: 2021 PMID: 32992344 PMCID: PMC7976441 DOI: 10.1182/blood.2020007039
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113